BREATHE Long-Term Follow-Up Study
Completed
- Conditions
- Chronic Sinus Disease
- Registration Number
- NCT01319305
- Lead Sponsor
- Entellus Medical, Inc.
- Brief Summary
This is a long-term follow-up of patients that participated in the BREATHE I study.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 70
Inclusion Criteria
- Participated in BREATHE I study
- Willing to sign consent and participate in long-term follow-up study
Exclusion Criteria
- None
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method SNOT-20 scores approximately 24 months Assess post-procedure outcomes defined as SNOT-20 scores and work productivity assessment questionnaires aproximately 24 months post-procedure
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms underlie FinESS Sinus Treatment's efficacy in chronic sinus disease patients?
How does FinESS Sinus Treatment compare to balloon sinuplasty in long-term outcomes for chronic rhinosinusitis?
Are there specific biomarkers that predict response to FinESS therapy in nasal polyp or fungal sinusitis subtypes?
What adverse events are associated with endoscopic sinus surgery devices like FinESS in long-term follow-up studies?
What are the potential combination therapies involving FinESS and biologics for refractory chronic sinus disease?
Trial Locations
- Locations (1)
St. Cloud ENT
🇺🇸St. Cloud, Minnesota, United States
St. Cloud ENT🇺🇸St. Cloud, Minnesota, United States